Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Chemical manufacturer appointed by MNLpharma
August 15th, 2005
SAFC announced that MNLpharma Ltd (MNL) has appointed the company to provide chemical development and GMP manufacturing services for its drug discovery and development program. The services will target MNL's lead candidate from its small molecule immunomodulator program, MNLP462a, a cancer immunotherapeutic. MNL is developing next generation glycotherapeutics, including imino sugars for use as immunomodulators. Imino sugars are naturally occurring analogues or mimics of sugars and MNL has demonstrated that these molecules and synthetic analogues can stimulate dendritic cells to produce IL-12; a key cytokine for efficacious cancer...
Source: Pharma Business Week (2005-08-15)
|
